Back

The initial melanoma T cell infiltrate is defined by tissue-resident programs restrained by regulatory T cells

Williams, J. B.; Pant, S. M.; Kley, A. L.; Rajmalani, B. A.; Yapp, C.; Zhang, J.; Rotrosen, E.; Sales, A.; Sorger, P. K.; Kupper, T. S.

2026-06-18 immunology
10.1101/2025.10.21.683143 bioRxiv
Show abstract

How the immune system surveys nascent tumors and how this surveillance is subverted remain poorly understood. Using high-plex cyclic immunofluorescence and 3D imaging, we identified regulatory T (Treg) cells that co-localize with tissue-resident memory (TRM)-like T cells in early-stage human melanoma. In an autochthonous Braf/PTEN melanoma model expressing a defined tumor antigen, the initial CD8+ T cell infiltrate adopts a CD103+CD101+ TRM-like fate, establishing active immunosurveillance within nascent lesions. TRM-like cells dominate early tumors, occupy a stable epidermal niche, express effector molecules, and initiate T cell recruitment. However, Treg cells adopt a parallel tissue-resident phenotype, co-localizing with TRM-like cells and restraining both cytotoxic and sentinel functions. Tumor-site-specific Treg depletion reactivated TRM-like cells, drove robust T cell recruitment, expanded tumor-specific responses, and limited tumor growth. These findings reveal how early immunosurveillance is established through tissue-resident programs and identify Treg co-option of this response as a critical mechanism of tumor immune evasion. One Sentence SummaryNascent melanoma imprints a tissue-resident program on the initial CD8+ T cell infiltrate, which is suppressed by regulatory T cells as a critical checkpoint in immune evasion.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Science Immunology
88 papers in training set
Top 0.1%
18.2%
2
Nature Communications
5641 papers in training set
Top 16%
11.7%
3
Cell Reports
1498 papers in training set
Top 2%
10.4%
4
Immunity
67 papers in training set
Top 0.2%
7.1%
5
Cancer Immunology Research
35 papers in training set
Top 0.1%
6.6%
50% of probability mass above
6
Journal of Experimental Medicine
119 papers in training set
Top 0.4%
5.1%
7
Cell
431 papers in training set
Top 2%
5.1%
8
Nature Immunology
79 papers in training set
Top 0.7%
4.0%
9
Journal for ImmunoTherapy of Cancer
75 papers in training set
Top 0.6%
3.4%
10
eLife
5828 papers in training set
Top 35%
3.2%
11
Cell Reports Medicine
153 papers in training set
Top 2%
1.9%
12
Journal of Clinical Investigation
179 papers in training set
Top 3%
1.9%
13
Science Advances
1243 papers in training set
Top 20%
1.7%
14
Cancer Cell
42 papers in training set
Top 0.9%
1.3%
15
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 36%
1.1%
16
Cancer Research
130 papers in training set
Top 3%
1.1%
17
Cancer Discovery
66 papers in training set
Top 1%
1.1%
18
JCI Insight
277 papers in training set
Top 7%
1.0%
19
Nature
645 papers in training set
Top 10%
1.0%
20
Nature Cancer
39 papers in training set
Top 1%
0.8%
21
iScience
1154 papers in training set
Top 36%
0.8%
22
Science
477 papers in training set
Top 10%
0.6%
23
Med
39 papers in training set
Top 1.0%
0.6%